Literature DB >> 23100328

ORMDL3 modulates store-operated calcium entry and lymphocyte activation.

Amado Carreras-Sureda1, Gerard Cantero-Recasens, Fanny Rubio-Moscardo, Kerstin Kiefer, Christine Peinelt, Barbara A Niemeyer, Miguel A Valverde, Rubén Vicente.   

Abstract

T lymphocytes rely on a Ca(2+) signal known as store-operated calcium entry (SOCE) for their activation. This Ca(2+) signal is generated by activation of a T-cell receptor, depletion of endoplasmic reticulum (ER) Ca(2+) stores and activation of Ca(2+) release-activated Ca(2+) currents (I(CRAC)). Here, we report that the ER protein orosomucoid like 3 (ORMDL3), the product of the ORMDL3 gene associated with several autoimmune and/or inflammatory diseases, negatively modulates I(CRAC), SOCE, nuclear factor of activated T cells nuclear translocation and interleukin-2 production. ORMDL3 inhibits the Ca(2+) influx mechanism at the outer mitochondrial membrane, resulting in a Ca(2+)-dependent inhibition of I(CRAC) and reduced SOCE. The effect of ORMDL3 could be mimicked by interventions that decreased mitochondrial Ca(2+) influx and reverted by buffering of cytosolic Ca(2+) or activation of mitochondrial Ca(2+) influx. In conclusion, ORMDL3 modifies key steps in the process of T-lymphocyte activation, providing a functional link between the genetic associations of the ORMDL3 gene with autoimmune and/or inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100328     DOI: 10.1093/hmg/dds450

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  30 in total

1.  Genetic Variants Predisposing Most Strongly to Type 1 Diabetes Diagnosed Under Age 7 Years Lie Near Candidate Genes That Function in the Immune System and in Pancreatic β-Cells.

Authors:  Jamie R J Inshaw; Antony J Cutler; Daniel J M Crouch; Linda S Wicker; John A Todd
Journal:  Diabetes Care       Date:  2019-09-26       Impact factor: 19.112

2.  Aberrant ORM (yeast)-like protein isoform 3 (ORMDL3) expression dysregulates ceramide homeostasis in cells and ceramide exacerbates allergic asthma in mice.

Authors:  Clement Oyeniran; Jamie L Sturgill; Nitai C Hait; Wei-Ching Huang; Dorit Avni; Michael Maceyka; Jason Newton; Jeremy C Allegood; Alison Montpetit; Daniel H Conrad; Sheldon Milstien; Sarah Spiegel
Journal:  J Allergy Clin Immunol       Date:  2015-04-02       Impact factor: 10.793

3.  Coordinated regulation of the orosomucoid-like gene family expression controls de novo ceramide synthesis in mammalian cells.

Authors:  Kerstin Kiefer; Amado Carreras-Sureda; Roberto García-López; Fanny Rubio-Moscardó; Josefina Casas; Gemma Fabriàs; Rubén Vicente
Journal:  J Biol Chem       Date:  2014-12-17       Impact factor: 5.157

Review 4.  Orm/ORMDL proteins: Gate guardians and master regulators.

Authors:  Deanna Davis; Muthukumar Kannan; Binks Wattenberg
Journal:  Adv Biol Regul       Date:  2018-08-31

5.  Oroscomucoid like protein 3 (ORMDL3) transgenic mice have reduced levels of sphingolipids including sphingosine-1-phosphate and ceramide.

Authors:  Marina Miller; Peter Rosenthal; Andrew Beppu; Ruth Gordillo; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2016-11-05       Impact factor: 10.793

6.  The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice.

Authors:  Nincy Debeuf; Assem Zhakupova; Regula Steiner; Sofie Van Gassen; Kim Deswarte; Farzaneh Fayazpour; Justine Van Moorleghem; Karl Vergote; Benjamin Pavie; Kelly Lemeire; Hamida Hammad; Thorsten Hornemann; Sophie Janssens; Bart N Lambrecht
Journal:  J Allergy Clin Immunol       Date:  2019-07-20       Impact factor: 10.793

Review 7.  ORMDL3 and allergic asthma: From physiology to pathology.

Authors:  Briana James; Sheldon Milstien; Sarah Spiegel
Journal:  J Allergy Clin Immunol       Date:  2019-07-31       Impact factor: 10.793

8.  Negative regulatory roles of ORMDL3 in the FcεRI-triggered expression of proinflammatory mediators and chemotactic response in murine mast cells.

Authors:  Viktor Bugajev; Ivana Halova; Lubica Draberova; Monika Bambouskova; Lucie Potuckova; Helena Draberova; Tomas Paulenda; Sergi Junyent; Petr Draber
Journal:  Cell Mol Life Sci       Date:  2015-09-25       Impact factor: 9.261

9.  ORMDL3 transgenic mice have increased airway remodeling and airway responsiveness characteristic of asthma.

Authors:  Marina Miller; Peter Rosenthal; Andrew Beppu; James L Mueller; Hal M Hoffman; Arvin B Tam; Taylor A Doherty; Matthew D McGeough; Carla A Pena; Maho Suzukawa; Maho Niwa; David H Broide
Journal:  J Immunol       Date:  2014-03-12       Impact factor: 5.422

10.  ORMDL3 expression in ASM regulates hypertrophy, hyperplasia via TPM1 and TPM4, and contractility.

Authors:  Alexa K Pham; Marina Miller; Peter Rosenthal; Sudipta Das; Ning Weng; Sunghoon Jang; Richard C Kurten; Jana Badrani; Taylor A Doherty; Brian Oliver; David H Broide
Journal:  JCI Insight       Date:  2021-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.